期刊文献+

甲状腺机能亢进症患者部分骨代谢生化指标的变化及分析 被引量:3

Determination of partial biochemical markers of bone metabolism in patients with hyperthyroidism
下载PDF
导出
摘要 目的 查明甲状腺机能亢进症患者血清骨钙素 (BGP)、碱性磷酸酶 (AL P)及尿羟脯氨酸 (HOP) ,观察其变化并进行分析。方法 以 30例甲亢患者及 15例正常人为研究对象 ,测定 BGP、AL P、尿 HOP等指标。结果 甲亢患者血清 BGP(11.18± 4.74) ng/ m l和尿 HOP(2 4.32± 11.2 1) mg/ g.Cr均高于正常对照组 (P <0 .0 5)。 Objective To observe and analyse the changes of partial biochemical markers in patients with hyperthyroidism.Methods We determinate the levels of BGP,ALP,HOP in 30 patients with hyperthyroidism and 15 normal subjects.Results The levels of serum BGP (11.18±4.74) ng/ml andurine HOP (24.32±11.21) mg/g.Cr in hyperthyroid group were higher than those in the control one.Conclusions The increasing of bone resorption and the relative decreasing of bone formation might lead to abnormal bone metabolism in hyperthyroidism.
出处 《中国地方病学杂志》 CAS CSCD 2000年第6期409-410,共2页 Chinese Jouranl of Endemiology
关键词 甲状腺机能亢进 骨代谢 骨钙素 尿羟脯氨酸 Hyperthyroidism Abnormal bone metabolism BGP d
  • 相关文献

参考文献3

二级参考文献8

  • 1王维力,天津医药,1984年,12卷,6期,330页
  • 2廉宗--,中华放射学杂志,1982年,16卷,1期,32页
  • 3朱镛连,中华内科杂志,1986年,25卷,9期,521页
  • 4宋峰生,中华神经精神科杂志,1986年,19卷,4期,217页
  • 5郑少雄,中华医学检验杂志,1983年,6卷,3期,133页
  • 6王湘兵,湖南医科大学学报,1987年,12卷,2期,183页
  • 7汪恕萍,新医学,1985年,16卷,9期,470页
  • 8W. Farrugia,R. A. Melick. Metabolism of osteocalcin[J] 1986,Calcified Tissue International(4):234~238

共引文献41

同被引文献36

  • 1柴瑞敏,刘薇,叶志明,于湄,徐丽梅,杨丽萍,王雪,詹志伟.甲状腺功能亢进患者骨代谢变化的研究[J].中华内分泌代谢杂志,1998,14(2):93-96. 被引量:14
  • 2欧文新,戚子惠.53例甲状腺功能亢进患者血清中钙磷镁的水平与骨质疏松的关系[J].广东医学,2006,27(7):1068-1069. 被引量:7
  • 3李晓莉,林小波,伍华,谢乃强.甲状腺功能亢进患者骨密度与骨代谢生化指标的改变[J].中国煤炭工业医学杂志,2007,10(2):132-133. 被引量:7
  • 4陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 5陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 6Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk-a meta-analysis [ J]. Thyroid ,2003,13 (6) :585 - 93.
  • 7Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroid- ism and hypothyroidism:a nationwide follow-up study in 16,249 pa- tients[J]. Thyroid,2002,12(5) :411 -419.
  • 8Liu G, Peacock M. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture [ J ]. Calcif Tissue Int, 1998,62 (4) :286 - 289.
  • 9Eriksen EF,Charles P,Melsen F,et al. Serum markers of type I col- lagen formation and degradation in metabolic bone disease:correla- tion with bone histomorphometry [ J ]. J Bone Miner Res, 1993, 8(2) :127 -132.
  • 10Charles P, Mosekilde L, Risteli L, et al. Assessment of bone remode- ling using biochemical indicators of type I collagen synthesis and degradation : relation to calcium kinetics [ J ]. Bone Miner, 1994,24 ( 2 ) : 81 -94.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部